AtriCure, Inc. (ATRC) Stock Price

ATRCStock

$48.68+30.86%52W

Market Cap$2.48B

P/E—

PEG Ratio10.00

Div yield—

Beta1.27

ATRC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)41.51%

Price vs S&P 500 (4W)20.92%

PEG Ratio10.00

VGM Score61.70

P/CF (Annual)38.58x

Book Value / Share (Quarterly)$10.15

P/TBV (Annual)4.43x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)17.39%

Cash Flow / Share (Quarterly)$1.02

Price vs S&P 500 (YTD)12.61%

Gross Margin (TTM)76.30%

Net Profit Margin (TTM)1.85%

EPS (TTM)$0.22

10-Day Avg Trading Volume0.64M

EPS Excl Extra (TTM)$0.22

Revenue Growth (5Y)20.95%

EPS (Annual)$-0.24

ROI (Annual)-2.04%

Gross Margin (Annual)74.98%

Net Profit Margin (5Y Avg)-3.03%

Cash / Share (Quarterly)$3.30

P/E Basic Excl Extra (TTM)209.65x

Revenue Growth QoQ (YoY)12.83%

ROA (Last FY)-1.75%

Revenue Growth TTM (YoY)13.94%

EBITD / Share (TTM)$0.33

ROE (5Y Avg)-3.67%

Operating Margin (TTM)2.26%

Cash Flow / Share (Annual)$0.85

P/B Ratio4.28x

P/B Ratio (Quarterly)2.74x

Net Income / Employee (Annual)$-8,500

EV / Revenue (TTM)3.71x

Net Interest Coverage (TTM)-6.26x

ROA (TTM)1.62%

EV / EBITDA (TTM)133.02x

EPS Incl Extra (Annual)$-0.24

Current Ratio (Annual)3.96x

Quick Ratio (Quarterly)3.02x

3-Month Avg Trading Volume0.89M

52-Week Price Return30.86%

EV / Free Cash Flow (Annual)49.95x

P/E Incl Extra (TTM)209.65x

Revenue / Employee (TTM)$421,900

Tangible BV / Share (Quarterly)$9.30

P/S Ratio (Annual)4.14x

Asset Turnover (Annual)0.82x

52-Week High$49.88

Operating Margin (5Y Avg)-2.03%

EPS Excl Extra (Annual)$-0.24

CapEx CAGR (5Y)23.40%

Tangible BV CAGR (5Y)9.33%

26-Week Price Return52.76%

Quick Ratio (Annual)2.87x

13-Week Price Return70.99%

Total Debt / Equity (Annual)0.14x

Current Ratio (Quarterly)4.22x

Enterprise Value$2.11B

Revenue / Share Growth (5Y)17.94%

Asset Turnover (TTM)0.87x

Book Value / Share Growth (5Y)1.65%

Revenue / Employee (Annual)$395,900

Inventory Turnover (Annual)1.74x

Pretax Margin (Annual)-1.90%

Cash / Share (Annual)$3.36

3-Month Return Std Dev47.55%

Gross Margin (5Y Avg)74.88%

Net Income / Employee (TTM)$7,800

ROE (Last FY)-2.33%

Net Interest Coverage (Annual)18.03x

EPS Basic Excl Extra (Annual)$-0.24

P/FCF (TTM)36.89x

Receivables Turnover (TTM)7.80x

EV / Free Cash Flow (TTM)40.53x

Total Debt / Equity (Quarterly)0.13x

EPS Incl Extra (TTM)$0.22

Receivables Turnover (Annual)8.42x

ROI (TTM)1.88%

P/S Ratio (TTM)3.88x

Pretax Margin (5Y Avg)-2.88%

Revenue / Share (Annual)$11.19

Tangible BV / Share (Annual)$8.92

Forward P/E126.92x

Price vs S&P 500 (52W)12.54%

P/E Ratio (TTM)209.65x

Year-to-Date Return24.57%

5-Day Price Return7.69%

EPS Normalized (Annual)$-0.24

ROA (5Y Avg)-2.77%

Net Profit Margin (Annual)-2.14%

Month-to-Date Return30.51%

Cash Flow / Share (TTM)$-0.24

EBITD / Share (Annual)$-0.13

Operating Margin (Annual)-1.77%

LT Debt / Equity (Annual)0.13x

P/CF (TTM)34.07x

ROI (5Y Avg)-3.18%

P/E Excl Extra (TTM)209.65x

LT Debt / Equity (Quarterly)0.12x

EPS Basic Excl Extra (TTM)$0.22

P/TBV (Quarterly)2.99x

P/B Ratio (Annual)4.00x

Inventory Turnover (TTM)1.68x

Pretax Margin (TTM)2.12%

Book Value / Share (Annual)$9.88

Price vs S&P 500 (13W)68.20%

Beta1.27x

P/FCF (Annual)52.32x

Revenue / Share (TTM)$11.66

ROE (TTM)2.14%

52-Week Low$25.36

vGradeD

gGradeB

mGradeA

vgmGradeB

ATRC Earnings Surprise History

Q2 25-0.02est. -0.16

Q3 25-0.01est. -0.12

Q4 250.06est. -0.04

Q1 260.00est. -0.06

Q2 260.18est. 0.02

ATRC Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.06

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
ATRCAtriCure, Inc.	D	B	A	$48.68
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16
SIShoulder Innovations, Inc.	—	B	A	$22.32

About AtriCure, Inc.

AtriCure develops surgical solutions for treating atrial fibrillation, managing left atrial appendage, and alleviating post-operative pain in cardiac and thoracic procedures. Its product portfolio includes cryoablation, radiofrequency ablation, and nerve pain management technologies used in open-heart and minimally invasive surgical settings. The company sells through direct sales and distributors, with the majority of revenue from the United States.